ArticleFrontiers in medicine2026

Development and validation of an artificial intelligence proof-of-concept tool for risk-based quality assessment of generic medicines: a South African case study.

Lorraine Danks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.